483 Shandong Anhong Pharmaceutical Feb 2019

483 Shandong Anhong Pharmaceutical Feb 2019

Joel Hustedt FDA$119.00 - Available Now

FDA investigators audited the Shandong Anhong Pharmaceutical - Dezhou, China facility and issued inspectional observations (via FDA 483) on 22 Feb 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 22 Feb 2019
  • Location: Dezhou, China
  • FEI: 3003877289
Add To Cart